Savara Inc. Files 8-K with Financials and Exhibits

Ticker: SVRA · Form: 8-K · Filed: Sep 2, 2025 · CIK: 1160308

Savara Inc 8-K Filing Summary
FieldDetail
CompanySavara Inc (SVRA)
Form Type8-K
Filed DateSep 2, 2025
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: 8-K, financial-statements, exhibits

TL;DR

Savara Inc. filed an 8-K with financials & exhibits. Routine disclosure.

AI Summary

On September 2, 2025, Savara Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating routine corporate disclosures rather than a specific material event. The company, formerly known as Mast Therapeutics, Inc., is incorporated in Delaware and based in Austin, TX.

Why It Matters

This 8-K filing serves as a standard disclosure of financial statements and exhibits, providing transparency to investors about the company's financial health and reporting practices.

Risk Assessment

Risk Level: low — The filing is a routine 8-K for financial statements and exhibits, not indicating any immediate material adverse events.

Key Players & Entities

  • Savara Inc. (company) — Registrant
  • Mast Therapeutics, Inc. (company) — Former company name
  • September 2, 2025 (date) — Date of report
  • Delaware (jurisdiction) — State of incorporation
  • Austin, TX (location) — Business address city and state

FAQ

What is the primary purpose of this 8-K filing for Savara Inc.?

The primary purpose of this 8-K filing is to report financial statements and exhibits.

What is Savara Inc.'s state of incorporation?

Savara Inc. is incorporated in Delaware.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on September 2, 2025.

What was Savara Inc.'s former company name?

Savara Inc.'s former company name was Mast Therapeutics, Inc.

Where is Savara Inc.'s principal executive office located?

Savara Inc.'s principal executive office is located at 1717 Langhorne Newtown Road, Suite 300, Langhorne, PA 19047.

Filing Stats: 567 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2025-09-02 09:13:41

Key Financial Figures

  • $0.001 — ich registered Common Stock, par value $0.001 per share SVRA The Nasdaq Global Se

Filing Documents

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Savara Corporate Presentation 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 2, 2025 SAVARA INC. a Delaware corporation By: /s/ Dave Lowrance Dave Lowrance Chief Financial & Administrative Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.